More detailed investigation on the localization of miRNAs in the brain and the potential association between transcription factors and miRNAs related to MAO-A regulation would be necessary to further discuss the potential of these miRNAs as therapeutic targets to control MAO-A in specific brain regions related to the pathophysiology of depression. This evidence concerns the gene MAOA and depressive symptom measurement.